Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

Oxford/AstraZeneca COVID vaccine roll-out suspended in South Africa

Johnson Uche by Johnson Uche
February 8, 2021
in Coronavirus, Spotlight
AstraZeneca to supply two million doses of Covid-19 vaccine weekly from mid-January
Share on FacebookShare on TwitterShare on Linkedin

South Africa has decided to suspend the rollout of the Oxford/AstraZeneca coronavirus vaccine pending when it is properly advised by experts on the best way to proceed.

This was disclosed by the Health Minister, Zweli Mkhize, after trial data showed the vaccine developed by the drug maker, AstraZeneca and the University of Oxford offered only limited protection against coronavirus variant first identified in South Africa.

According to Mkhize, “When new information is brought to light and viruses change and mutate, decisions need to be made. This is possibly why the AstraZeneca vaccine rollout is on hold for now. In the next few weeks, South Africa will have the J&J and Pfizer vaccine.”

RelatedPosts

FG says Nigeria gathering vaccine producers to develop technology in case of future outbreaks

You can now go to United States without COVID-19 tests

READ: COVID-19: Evidence suggests that new variants could pose challenge for vaccines

What you should know

  • South Africa had planned to roll the Oxford/AstraZeneca shot out to healthcare workers.
  • The University of Witwatersrand in Johannesburg recently conducted a trial of the Oxford/AstraZeneca vaccine and stated that the vaccine provides minimal protection against the new variant, which is dominant in South Africa.

READ: Britain struggles to contain Covid mutations

According to a report by Aljazeera:

  • “AstraZeneca said none of the 2,000 participants near the age of 31 developed serious symptoms. That could mean it will still have an effect on severe disease, although there is not yet enough data to make a definitive judgment.
  • “The company has started adapting its vaccine against the variant and will advance rapidly through clinical development so that it is ready for autumn delivery should it be needed.”

READ: UK scientists worry vaccines may not work on South African Covid-19 strain

In the alternative, South Africa intends to offer vaccines developed by Johnson & Johnson (J&J) and Pfizer in the coming weeks while experts consider how the AstraZeneca shot can be deployed.

Related

Tags: AstraZenecaCovid-19 vaccineUniversity of Oxford

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Hot forex
Cornerstone
Mega Millions
Polaris Bank
Access Bank
Bankers Committee
First bank


FCMB
Ikeja Electrics




    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • Bulls are back: Nigerian stock market gains N8 billion
    • Why court awarded Nigerian musician N20 million in damages against MTN, others
    • Dangote Cement appoints Dr. Gbenga Fapohunda as Acting Group Chief Finance Officer

    Follow us on social media:

    Recent News

    Nigerian stock market dips 0.57% as investors part with N117 billion

    Bulls are back: Nigerian stock market gains N8 billion

    June 30, 2022
    Federal Government Vs Petro Union: $15 billion case resumes today

    Why court awarded Nigerian musician N20 million in damages against MTN, others

    June 30, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com